Accelerate life-saving treatments.

Clinical trial execution is an important, complex problem.

Today 50% of new treatments fail due to non drug efficacy-related reasons. 86% of clinical trial sites do not meet enrollment goals.

For clinical trials that do complete, there is a high degree of post-market failures due to relevance and applicability in real-world settings.

Macro is the answer.

MACRO is a new type of clinical research platform, purpose-built to execute on tomorrow's landscape of complex, decentralized trials.

We take a human approach to accelerating life-saving treatments, with patients at our core and an agile, outcomes-focused model.

Proven Track Record

100%
recruitment goals

exceeded in completed studies conducted by Macro

2.0x
faster enrollment

when compared to leading academic medical centers

90%
patient completion

rates for those who start their trial journey with Macro

1B-IV
trial experience

Phase IB, II, III, IV and post market study experience

Start your Next Trial with Macro Today

Get started

Accelerating trial timelines requires an agile model

Our turnkey, plug and play infrastructure is built for efficiency across in-person, virtual, and hybrid trials. Macro's certified, full-time clinical research team operates across Macro's remote platform and state-of-the-art clinical facilities.

Recruiting diverse populations requires a patient-centered approach

Our high-touch model leverages our deep understanding of patient needs, cultural competence and focuses on each engagement with the patient.

Complex and rare disease advancement requires specialized logistics

Our combined 40 years of industry experience and high-quality national network of logistics partners allows Macro to comply with evolving regulatory and compliance changes.

Enhancing trial success requires a new approach to data

Macro’s data analytics strategy helps optimize protocol design and patient selection across a sponsor’s drug development program.

Where We've Partnered

Therapeutic Areas

  • cardiology
  • ophthalmology
  • neurology
  • pulmonology
  • oncology
  • endocrinology
  • dermatology
  • autoimmune

Investigational Products

  • infusion biologics
  • subcutaneous biologics
  • intramuscular biologics
  • oral capsules
  • gene therapy
  • vitreoretinal injections

Study Settings

  • outpatient in-person
  • virtual (including in patient's home)
  • hybrid decentralized
  • satellite sites

Head-to-Head Comparison

In a biologic trial for a rare disease, Macro recruited nearly 3x as many patients as a leading academic institution and began the trial 5 months earlier.
Casestudy diagram

FAQs

Rare Disease Trials Create Common Burdens

March 2, 2020

In time for Rare Disease Day, orphan-disease patients, site managers and service providers discuss challenges obstacles faced in trial participation.

Read More

MACRO Trials’ Clinical Trial Model Continues to Thrive Despite COVID-19

May 18, 2020

MACRO Trials (MACRO) is shifting the paradigm for performing clinical trials through a progressive, streamlined model that has emerged particularly steadfast during the COVID-19 crisis.

Read More

MACRO Trials Partners with CRIO To Accelerate Geographic and Demographic Expansion

September 3, 2020

MACRO Trials (MACRO) continues to expand the company’s capabilities to assist physicians who desire to perform clinical trials outside the mired traditional institutional research process.

Read More